LCN2 and obesity disorder: Based on the presumption that obesity-related worsening of OA symptoms and progression is associated with the low-grade inflammation as shown by increased NGAL-levels, we hypothesized that NGAL-levels would decrease in response to both the initial weight loss treatment and the subsequent GLP-1 RA treatment.